Practice Areas

  • Advising banks, financial and payments service providers and asset management companies on regulatory issues
  • Sustainable Finance, MiFID II
  • Advising institutional investors on capital investments
Show moreShow less
Education and Professional Experience
  • Lawyer at GSK Stockmann since 2022
  • Worked in the capital markjet practice of a leading international law firm in Frankfurt
  • Admitted to practise law in Germany (2018)
  • Doctorate from the University of Augsburg
  • Studies at the University of Tasmania, Hobart (AUS)
Languages
  • English, French, German, Italian
Publications
  • Lorenz, Philippe / Stolz, Dominik: Auf dem Weg zur grüneren und nachhaltigeren Zukunft, Börsenzeitung – Sonderbeilage Green Finance vom 25.05.2024, S. 29
  • Wellerdt, Alexander / Stolz, Dominik: Nachhaltige Investments glaubhaft regulieren, in: EuR 2023, S: 181-197
  • Lorenz, Philippe / Stolz, Dominik: Regulatorik-Anforderungen in der Portfolioverwaltung, Börsenzeitung – Sonderbeilage ESG vom 12. Oktober 2022, Seite B9.
  • Wellerdt, Alexander / Stolz, Dominik: Das (un)grüne Risiko – Nachhaltigkeits-Risikofaktoren in Wertpapierprospekten, in: WM 2022, S. 654-658
  • Wellerdt, Alexander / Stolz, Dominik: Exchange Traded Notes – wie Bitcoin zu einem regulierten Wertpapier werde, in: BKR 2021, S. 479-483
  • Stolz, Dominik: Die demokratische Legitimation der Europäischen Wertpapier- und Marktaufsichtsbehörde und ihrer Rechtsakte, in: Augsburger Rechtsstudien 2020.
Deal News
09 December 2024

GSK Stockmann advises Catella on strategic merger of two subsidiaries

GSK Stockmann supported the Swedish Catella Group with the strategic merger of two of its German subsidiaries, Catella Residential Investment Management (CRIM) in Berlin and C...

Read more
GSK Updates
12 February 2024

ESG regulation – an outlook on developments for the year 2024

Today’s financial world is characterised by multiple change processes taking place at a more intense and rapidly increasing pace than we have likely ever experienced before.

Read more
GSK Updates
23 October 2023

New unified standard for EU Green Bonds – Current developments

New voluntary standard for the use of the label as an Eu Green Bond

Read more
GSK Updates
04 April 2023

European Union institutions agree on a standard for EU Green Bonds – Current developments

The EU legislators reached a political agreement on the EU Green Bond Regulation on 2 March 2023. After lengthy negotiations, the first-ever uniform EU label for green bonds is to ...

Read more